CureGN network for primary glomerular (kidney) diseases
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
This project collects medical information and blood/urine samples from children and adults with primary glomerular kidney diseases like minimal change disease, FSGS, IgA nephropathy, and membranous nephropathy.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11166636 on NIH RePORTER |
What this research studies
You would join a network that follows people with primary glomerular diseases over time and gathers clinical data, patient-reported outcomes, and biospecimens (blood, urine, tissue when available). The study has enrolled nearly 2,800 adults and children at more than 60 clinical sites and is run by a coordinated Data Coordinating Center and several participating clinical centers. Collected samples and data support a range of research projects on disease causes, how disease progresses, and why people respond differently to treatments. Participation may involve clinic visits, questionnaires, and sample collection at a nearby study site.
Who could benefit from this research
Good fit: People of any age (children and adults) diagnosed with primary glomerular diseases—minimal change disease, focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IgAN), or membranous nephropathy (MN)—are the ideal candidates.
Not a fit: People without these primary glomerular diagnoses, those with kidney disease from other known secondary causes, or those already on long-term dialysis may not directly benefit from this project.
Why it matters
Potential benefit: If successful, this work could help doctors better diagnose causes of glomerular diseases and guide more effective, personalized treatments in the future.
How similar studies have performed: This is an established, large observational network that has already recruited a diverse cohort and supported multiple translational studies rather than being a brand-new, untested approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Bomback, Andrew Stephen — Columbia University Health Sciences
- Study coordinator: Bomback, Andrew Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.